| Citation: |
ZHAO Honghui, WANG Yudong. Research Progress on Role of Probiotic Akkermansia Muciniphila in Oncogenesis, Development and Treatment of Tumor[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 408-412. DOI: 10.3971/j.issn.1000-8578.2023.22.1087
|
Although tumor treatment models have been continuously improved in clinical practice, cancer remains a serious threat to human health. The effect of probiotics on tumor therapy has received extensive attention. As a common colonizer of the intestinal mucosa, Akkermansia muciniphila(AKK) has a well-defined role in metabolic diseases, but its complex role in tumor development and therapeutic efficacy has not been fully elucidated. The unique properties and physiological roles of AKK play an important role in different solid tumors and it may be a potential biomarker. This article provides a review of previous studies and proposes clinical strategies to influence the abundance of AKK to provide a theoretical reference for the development of next-generation probiotics and the reshaping of the tumor treatment landscape.
Competing interests: The authors declare that they have no competing interests.
| [1] |
Gupta VK, Paul S, Dutta C. Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity[J]. Front Microbiol, 2017, 8: 1162. doi: 10.3389/fmicb.2017.01162
|
| [2] |
Zhou Qi, Pang G, Zhang Z, et al. Association Between Gut Akkermansia and Metabolic Syndrome is Dose-Dependent and Affected by Microbial Interactions: A Cross-Sectional Study[J]. Diabetes Metab Syndr Obes, 2021, 14: 2177-2188. doi: 10.2147/DMSO.S311388
|
| [3] |
Xu R, Zhang Y, Chen S, et al. The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential[J]. Crit Rev Microbiol, 2022: 1-26.
|
| [4] |
Routy B, Le Chatelie E, Derosa L, et al. Gut micoinluences efficacy of PD-1-based immunotherapy against epitheliad tumors[J]. Science, 2018, 359(6371): 91-97. doi: 10.1126/science.aan3706
|
| [5] |
Gopalakrishnan V, Spencer CN, Nezi L, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients[J]. Science, 2018, 359(6371): 97-103. doi: 10.1126/science.aan4236
|
| [6] |
Belzer C, de Vos WM. Microbes inside--from diversity to function: The case of Akkermansia[J]. ISME J, 2012, 6(8): 1449-1458. doi: 10.1038/ismej.2012.6
|
| [7] |
Derrien M, Vaughan EE, Plugge CM, et al. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium[J]. Int J Syst Evol Microbiol, 2004, 54 (Pt 5): 1469-1476.
|
| [8] |
Guo X, Zhang J, Wu F, et al. Different subtype strains of Akkermansia muciniphila abundantly colonize in southern China[J]. J Appl Microbiol, 2016, 120(2): 452-459. doi: 10.1111/jam.13022
|
| [9] |
Shi M, Yue Y, Ma C, et al. Pasteurized Akkermansia muciniphila Ameliorate the LPS-Induced Intestinal Barrier Dysfunction via Modulating AMPK and NF-κB through TLR2 in Caco-2 Cells[J]. Nutrients, 2022, 14(4): 764. doi: 10.3390/nu14040764
|
| [10] |
Bae M, Cassilly CD, Liu XP, et al. Akkermansia muciniphila phospholipid induces homeostatic immune responses[J]. Nature, 2022, 608(7921): 168-173. doi: 10.1038/s41586-022-04985-7
|
| [11] |
Grander C, Adolph TE, Wieser V, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease[J]. Gut, 2018, 67(5): 891-901. doi: 10.1136/gutjnl-2016-313432
|
| [12] |
Huck O, Mulhall H, Rubin G, et al. Akkermansia muciniphila reduces Porphyromonas gingivalis-induced inflammation and periodontal bone destruction[J]. J Clin Periodontol, 2020, 47(2): 202-212. doi: 10.1111/jcpe.13214
|
| [13] |
Reunanen J, Kainulainen V, Huuskonen L, et al. Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer[J]. Appl Environ Microb, 2015, 81 (11): 3655-3662. doi: 10.1128/AEM.04050-14
|
| [14] |
Chelakkot C, Choi Y, Kim DK, et al. Akkermansia muciniphila-derived extracellular vesicles influence gut permeability through the regulation of tight junctions[J]. Exp Mol Med, 2018, 50(2): e450. doi: 10.1038/emm.2017.282
|
| [15] |
Earley H, Lennon G, Balfe Á, et al. The abundance of Akkermansia muciniphila and its relationship with sulphated colonic mucins in health and ulcerative colitis[J]. Sci Rep, 2019, 9(1): 15683. doi: 10.1038/s41598-019-51878-3
|
| [16] |
Bian X, Wu W, Yang L, et al. Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice[J]. Front Microbiol, 2019, 10: 2259. doi: 10.3389/fmicb.2019.02259
|
| [17] |
Wang L, Tang L, Feng Y, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice[J]. Gut, 2020, 69 (11): 1988-1997. doi: 10.1136/gutjnl-2019-320105
|
| [18] |
Seregin SS, Golovchenko N, Schaf B, et al. NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila[J]. Cell Rep, 2017, 19 (4): 733-745. doi: 10.1016/j.celrep.2017.03.080
|
| [19] |
Baxter NT, Zackular JP, Chen GY, et al. Structure of the gut microbiome following colonization with human feces determines colonic tumor burden[J]. Microbiome, 2014, 2: 20. doi: 10.1186/2049-2618-2-20
|
| [20] |
Meng X, Zhang J, Wu H, et al. Akkermansia muciniphila Aspartic Protease Amuc_1434* Inhibits Human Colorectal Cancer LS174T Cell Viability via TRAIL-Mediated Apoptosis Pathway[J]. Int J Mol Sci, 2020, 21 (9): 3385. doi: 10.3390/ijms21093385
|
| [21] |
Fan L, Xu C, Ge Q, et al. A. Muciniphila Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs[J]. Cancer Immunol Res, 2021, 9 (10): 1111-1124. doi: 10.1158/2326-6066.CIR-20-1019
|
| [22] |
Wu F, Guo X, Zhang M, et al. An Akkermansia muciniphila subtype alleviates high-fat diet-induced metabolic disorders and inhibits the neurodegenerative process in mice[J]. Anaerobe, 2020, 61: 102138. doi: 10.1016/j.anaerobe.2019.102138
|
| [23] |
van der Beek CM, Dejong CHC, Troost FJ, et al. Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing[J]. Nutr Rev, 2017, 75(4): 286-305. doi: 10.1093/nutrit/nuw067
|
| [24] |
Hou X, Zhang P, Du H, et al. Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer[J]. Front Pharmacol, 2021, 12: 725583. doi: 10.3389/fphar.2021.725583
|
| [25] |
Li J, Li J, Wang H, et al. Tyrosine and Glutamine-Leucine Are Metabolic Markers of Early-Stage Colorectal Cancers[J]. Gastroenterology, 2019, 157(1): 257-259.e5. doi: 10.1053/j.gastro.2019.03.020
|
| [26] |
Derosa L, Routy B, Thomas AM, et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer[J]. Nat Med, 2022, 28(2): 315-324. doi: 10.1038/s41591-021-01655-5
|
| [27] |
Chen Z, Qian X, Chen S, et al. Akkermansia muciniphila Enhances the Antitumor Effect of Cisplatin in Lewis Lung Cancer Mice[J]. J Immunol Res, 2020, 2020: 2969287.
|
| [28] |
张卫东, 江刚, 吴怀球, 等. 细胞核相关抗原(Ki67)和p53表达对非小细胞肺癌患者预后的意义[J]. 中国现代医学杂志, 2018, (27): 57-63. doi: 10.3969/j.issn.1005-8982.2018.27.011
Zhang WD, Jiang G, Wu HQ, et al. Prognostic significance of Ki67 and p53 in non-small cell lung cancer patients[J]. Zhongguo Xian Dai Yi Xue Za Zhi, 2018, (27): 57-63. doi: 10.3969/j.issn.1005-8982.2018.27.011
|
| [29] |
Xu B, Zhang AM, Li F, et al. XZ-1 regulates cell apoptosis of gastric epithelial dysplasia via NF-κB/p53/Ki67 signaling pathway[J]. Biosci Rep, 2018, 38(3): BSR20171529. doi: 10.1042/BSR20171529
|
| [30] |
Luo ZW, Xia K, Liu YW, et al. Extracellular Vesicles from Akkermansia muciniphila Elicit Antitumor Immunity Against Prostate Cancer via Modulation of CD8+ T Cells and Macrophages[J]. Int J Nanomedicine, 2021, 16: 2949-2963. doi: 10.2147/IJN.S304515
|
| [31] |
Daisley BA, Chanyi RM, Abdur-Rashid K, et al. Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients[J]. Nat Commun, 2020, 11(1): 4822. doi: 10.1038/s41467-020-18649-5
|
| [32] |
Kim JR, Han K, Han Y, et al. Microbiome Markers of Pancreatic Cancer Based on Bacteria-Derived Extracellular Vesicles Acquired from Blood Samples: A Retrospective Propensity Score Matching Analysis[J]. Biology (Basel), 2021, 10 (3): 219.
|
| [33] |
Panebianco C, Adamberg K, Jaagura M, et al. Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice[J]. Cancer Chemoth Pharm, 2018, 81(4): 773-782. doi: 10.1007/s00280-018-3549-0
|
| [34] |
Okuda S, Hirose Y, Takihara H, et al. Unveiling microbiome profiles in human inner body fluids and tumor tissues with pancreatic or biliary tract cancer[J]. Sci Rep, 2022, 12(1): 8766. doi: 10.1038/s41598-022-12658-8
|
| [35] |
Kobayashi M, Mikami D, Uwada J, et al. A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells[J]. Oncotarget, 2018, 9(59): 31342-31354. doi: 10.18632/oncotarget.25809
|
| [36] |
Zheng Y, Wang T, Tu X, et al. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma[J]. J Immunother Cancer, 2019, 7(1): 193. doi: 10.1186/s40425-019-0650-9
|
| [37] |
Davar D, Dzutsev AK, McCulloch JA, et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients[J]. Science, 2021, 371(6529): 595-602. doi: 10.1126/science.abf3363
|
| [38] |
Baruch EN, Youngster I, Ben-Betzalel G, et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients[J]. Science, 2021, 371(6529): 602-609. doi: 10.1126/science.abb5920
|
| [39] |
Dizman N, Meza L, Bergerot P, et al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial[J]. Nat Med, 2022, 28(4): 704-712. doi: 10.1038/s41591-022-01694-6
|
| [40] |
Verhoog S, Taneri PE, Roa Díaz ZM, et al. Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review[J]. Nutrients, 2019, 11(7): 1565. doi: 10.3390/nu11071565
|
| [41] |
Long J, Zhang CJ, Zhu N, et al. Lipid metabolism and carcinogenesis, cancer development[J]. Am J Cancer Res, 2018, 8(5): 778-791.
|
| [42] |
Ejtahed HS, Soroush AR, Siadat SD, et al. Targeting obesity management through gut microbiota modulation by herbal products: A systematic review[J]. Complement Ther Med, 2019, 42: 184-204. doi: 10.1016/j.ctim.2018.11.019
|
| [43] |
Everard A, Lazarevic V, Gaïa N, et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity[J]. ISME J, 2014, 8(10): 2116-2130. doi: 10.1038/ismej.2014.45
|
| [44] |
Dubourg G, Lagier JC, Armougom F, et al. High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment[J]. Int J Antimicrob Agents, 2013, 41(2): 149-155. doi: 10.1016/j.ijantimicag.2012.10.012
|
| [45] |
Pflug N, Kluth S, Vehreschild JJ, et al. Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiota[J]. Oncoimmunology, 2016, 5(6): e1150399. doi: 10.1080/2162402X.2016.1150399
|
| [46] |
Nenclares P, Bhide SA, Sandoval-Insausti H, et al. Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy[J]. Eur J Cancer, 2020, 131: 9-15. doi: 10.1016/j.ejca.2020.02.047
|
| [47] |
Chen PB, Black AS, Sobel AL, et al. Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis[J]. Nat Biotechnol, 2020, 38(11): 1288-1297. doi: 10.1038/s41587-020-0549-5
|
| [48] |
Crawley AB, Henriksen JR, Barrangou R. CRISPRdisco: An Automated Pipeline for the Discovery and Analysis of CRISPR-Cas Systems[J]. CRISPR J, 2018, 1(2): 171-181. doi: 10.1089/crispr.2017.0022
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: